Andrew Scribner
Impact in
- Organic Chemistry top 10%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Catalytic C–H Functionalization Methods
- Multicomponent Synthesis of Heterocycles
- Synthesis and Reactivity of Heterocycles
- Synthesis and Characterization of Heterocyclic Compounds
Papers in
-
- Synthesis and Biological Evaluation 5
-
- Signaling Pathways in Disease 3
- Co-authors
- Michael Peel (4 shared papers)Dennis M. Schmatz (4 shared papers)Chris M. Brown (4 shared papers)D. R. Thompson (4 shared papers)Michael H. Fisher (4 shared papers)Anne Gurnett (4 shared papers)Tesfaye Biftu (4 shared papers)Penny Leavitt (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (4 papers)European Journal of Medicinal Chemistry (2 papers)Biochimica et Biophysica Acta (BBA) - General Subjects (1 paper)Journal of Hepatology (1 paper)Nuclear Medicine and Biology (1 paper)
- Partner nations
- United StatesUnited KingdomGreece
In The Last Decade
Andrew Scribner
14 papers receiving 246 citations
Peers
Comparison fields: 5 of 54
- Organic Chemistry 156
- Toxicology 12
- Animal Science and Zoology 16
- Small Animals 11
- Hepatology 8
Countries citing papers authored by Andrew Scribner
This map shows the geographic impact of Andrew Scribner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Scribner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Scribner more than expected).
Fields of papers citing papers by Andrew Scribner
This network shows the impact of papers produced by Andrew Scribner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Scribner. The network helps show where Andrew Scribner may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Scribner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 45 | |
| 2 | 2008 | 38 | |
| 3 | 2007 | 35 | |
| 4 | 2013 | 28 | |
| 5 | 2009 | 26 | |
| 6 | 2017 | 20 | |
| 7 | 1997 | 17 | |
| 8 | 2010 | 14 | |
| 9 | 2015 | 11 | |
| 10 | 1997 | 7 | |
| 11 | 1995 | 5 | |
| 12 | 2010 | 5 | |
| 13 | 2017 | 4 | |
| 14 | SCY-641 - A Water-Soluble Cyclophilin Inhibitor for the Treatment of Dry Eye Disease | 2011 | 2 |
About Andrew Scribner
Andrew Scribner is a scholar working on Organic Chemistry, Molecular Biology, Animal Science and Zoology, Small Animals and Genetics, having authored 14 papers that have together received 257 indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (5 papers), Coccidia and coccidiosis research (4 papers), Estrogen and related hormone effects (3 papers), Signaling Pathways in Disease (3 papers), Veterinary medicine and infectious diseases (3 papers), Combustion and flame dynamics (2 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Turbomachinery Performance and Optimization (2 papers). The work is most often cited by research in Organic Chemistry (156 citations), Toxicology (12 citations), Animal Science and Zoology (16 citations), Small Animals (11 citations) and Hepatology (8 citations). Andrew Scribner has collaborated with scholars based in United States, United Kingdom and Greece. Frequent co-authors include Michael Peel, Dennis M. Schmatz, Chris M. Brown, D. R. Thompson, Michael H. Fisher, Anne Gurnett, Tesfaye Biftu, Penny Leavitt, Paul Liberator and Matthew J. Wyvratt. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Biochimica et Biophysica Acta (BBA) - General Subjects, Journal of Hepatology and Nuclear Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.